Skip to content Skip to navigation

Drug testing company to serve plan members in three Northeast states

June 2, 2014
by Gary A. Enos, Editor
| Reprints

Baltimore-based drug testing company Ameritox has entered into an agreement with Northeast health insurer MVP Health Care to provide urine testing services for the insurance company's plan members in New York, New Hampshire and Vermont.

All MVP plans, including Medicaid and Medicare plans, will include Ameritox drug monitoring services as a covered benefit, according to a June 2 news release from both companies.

“This agreement will improve clinical care for MVP's members being treated with powerful prescription medications,” said Todd Gardner, Ameritox's chief operating officer. “With more medications being prescribed than ever, regular monitoring will help Ameritox and MVP Health Care recommend solutions that prevent the tragedy caused by medication misuse, abuse and diversion.”